Keywords: Novo Nordisk, Tresiba, UK and Denmark launch, Type 1 and 2 diabetes

Novo Nordisk debuts Tresiba in UK and Denmark

Article | 04 March 2013

Print This

Danish insulin giant Novo Nordisk (NOVN: N) has started the European roll-out of its Tresiba (insulin degludec), a new once-daily ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in